Related Experiment Video
Updated: Jan 16, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Multifunctional exosome-driven tumor immunotherapy sensitization: converting intratumoral bacteria into antitumor
Xiaoqing Wei1, Yongxin Zhang1, Yuxin Chen1
1Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, 610031, PR China.
Abstract:
Utilizing intratumoral bacteria to reprogram tumor-associated macrophages (TAMs) into a tumoricidal M1 phenotype holds great potential in cancer immunotherapy. However, intratumoral bacteria cunningly hide inside tumor cells to evade the surveillance of TAMs. Herein, we utilize dead tumor cells as bridges to connect TAMs with intratumoral bacteria. We constructed a multifunctional exosome loaded with ferroptosis inducer Fe3O4 nanoparticles and photothermal agent ICG to convert intratumoral bacteria into antitumor fighters to achieve tumor immunotherapy sensitization: 1) The multifunctional exosomes enable a synergistic enhancement of ferroptosis and photothermal therapy, efficiently inducing the death of tumor cells and intratumoral bacteria. 2) The killed tumor cells not only exhibit enhanced immunogenicity, but also promote the phagocytosis of hidden bacteria by macrophages when combined with CD47 blockade. 3) The engulfed bacteria could serve as antitumor fighters to polarize TAMs into tumoricidal M1 phenotype. The immunotherapy sensitization driven by the multifunctional exosomes provokes a robust antitumor immunity, promotes the intratumoral infiltration of T cells, and ultimately results in effective suppression of both tumor growth and metastasis.
Insights
This study uses dead tumor cells and exosomes loaded with iron nanoparticles and a photothermal agent to enhance cancer immunotherapy. This approach converts intratumoral bacteria into tumor-fighting agents, boosting immune responses against tumors and metastasis.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Immunotherapy
Background:
- Intratumoral bacteria can evade immune surveillance by hiding within tumor cells.
- Reprogramming tumor-associated macrophages (TAMs) to a tumoricidal M1 phenotype is a key strategy in cancer immunotherapy.
- Developing methods to effectively deliver therapeutic agents to intratumoral bacteria and enhance macrophage activity is crucial.
Purpose of the Study:
- To develop a multifunctional exosome-based system to sensitize cancer immunotherapy by targeting intratumoral bacteria.
- To investigate the synergistic effects of ferroptosis and photothermal therapy in inducing tumor cell and bacterial death.
- To enhance macrophage phagocytosis of bacteria and subsequent polarization into M1 phenotype.
Main Methods:
- Construction of multifunctional exosomes loaded with Fe3O4 nanoparticles (ferroptosis inducer) and ICG (photothermal agent).
- Utilizing dead tumor cells as a bridge to connect TAMs with intratumoral bacteria.
- Employing CD47 blockade to enhance macrophage phagocytosis of bacteria.
- Evaluating the therapeutic efficacy through synergistic ferroptosis and photothermal therapy, immune cell polarization, and tumor suppression.
Main Results:
- The multifunctional exosomes induced synergistic ferroptosis and photothermal therapy, leading to efficient tumor cell and intratumoral bacteria death.
- Killed tumor cells exhibited enhanced immunogenicity, and combined with CD47 blockade, promoted bacterial phagocytosis by macrophages.
- Engulfed bacteria successfully polarized TAMs into the tumoricidal M1 phenotype, enhancing antitumor immunity and T cell infiltration.
- The treatment resulted in significant suppression of tumor growth and metastasis.
Conclusions:
- Multifunctional exosomes effectively convert intratumoral bacteria into antitumor fighters, sensitizing cancer immunotherapy.
- The strategy overcomes bacterial evasion and enhances macrophage-mediated antitumor responses.
- This approach holds promise for effective cancer treatment by provoking robust antitumor immunity and suppressing tumor progression.
More Related Videos
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment